Literature DB >> 15210845

SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome.

Patricia G Yancey1, Bela F Asztalos, Nicolas Stettler, David Piccoli, David L Williams, Margery A Connelly, George H Rothblat.   

Abstract

Alagille syndrome is associated with bile duct paucity resulting in liver disease. Patients can be divided into mildly and severely icteric groups, with both groups having altered lipoproteins. The incidence of ischemic heart disease is rare in severely cholestatic children despite increased total cholesterol and decreased high density lipoprotein cholesterol (HDL-C). The present studies examine the impact of altered lipid and lipoproteins on scavenger receptor class B type I (SR-BI)- and ABCA1-mediated efflux to serum from both groups. Efflux was compared with serum from 29 patients (15 with normal plasma cholesteryl ester, 14 with low cholesteryl ester). Efflux via SR-BI and ABCA1 was studied using cell systems having either low or high expression levels of these receptors. SR-BI efflux was lower (P = 0.04) with serum from severely icteric patients (3.9 +/- 1.4%) compared with serum from mildly icteric patients (5.1 +/- 1.4%) and was positively correlated with HDL-C and its apolipoproteins. SR-BI-mediated efflux was not correlated with any particular mature HDL but was negatively correlated with small lipid-poor prebeta-1 HDL. Consistent with severely icteric patients having high prebeta-1 HDL levels, the ABCA1 efflux was significantly higher with their serum (4.8 +/- 2.2%) compared with serum from mildly icteric patients (2.0 +/- 0.6%) and was positively correlated with prebeta-1 HDL. These studies demonstrated that prebeta-1 HDL is the preferred acceptor for ABCA1 efflux, whereas many particles mediate SR-BI efflux. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210845     DOI: 10.1194/jlr.M400133-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol.

Authors:  Sandhya Sankaranarayanan; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; Bela F Asztalos; Robert Bittman; George H Rothblat
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

2.  Acute consumption of walnuts and walnut components differentially affect postprandial lipemia, endothelial function, oxidative stress, and cholesterol efflux in humans with mild hypercholesterolemia.

Authors:  Claire E Berryman; Jessica A Grieger; Sheila G West; Chung-Yen O Chen; Jeffrey B Blumberg; George H Rothblat; Sandhya Sankaranarayanan; Penny M Kris-Etherton
Journal:  J Nutr       Date:  2013-04-24       Impact factor: 4.798

3.  Inflammation impairs reverse cholesterol transport in vivo.

Authors:  Fiona C McGillicuddy; Margarita de la Llera Moya; Christine C Hinkle; Michelle R Joshi; Elise H Chiquoine; Jeffrey T Billheimer; George H Rothblat; Muredach P Reilly
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

4.  Hepatic proprotein convertases modulate HDL metabolism.

Authors:  Weijun Jin; Xun Wang; John S Millar; Thomas Quertermous; George H Rothblat; Jane M Glick; Daniel J Rader
Journal:  Cell Metab       Date:  2007-08       Impact factor: 27.287

5.  Cardiovascular Disease-Risk Markers in HIV Patients.

Authors:  Bela F Asztalos; Robert Matera; Katalin V Horvath; Michael Horan; Mariko Tani; Joseph F Polak; Sally Skinner; Christine A Wanke
Journal:  J AIDS Clin Res       Date:  2014-06-12

6.  Inclusion of Almonds in a Cholesterol-Lowering Diet Improves Plasma HDL Subspecies and Cholesterol Efflux to Serum in Normal-Weight Individuals with Elevated LDL Cholesterol.

Authors:  Claire E Berryman; Jennifer A Fleming; Penny M Kris-Etherton
Journal:  J Nutr       Date:  2017-06-14       Impact factor: 4.798

7.  A Case of Infantile Alagille Syndrome With Severe Dyslipidemia: New Insight into Lipid Metabolism and Therapeutics.

Authors:  Hisakazu Nakajima; Yusuke Tsuma; Shota Fukuhara; Kazuki Kodo
Journal:  J Endocr Soc       Date:  2022-01-18

Review 8.  Pathways and Mechanisms of Cellular Cholesterol Efflux-Insight From Imaging.

Authors:  Alice Dupont Juhl; Daniel Wüstner
Journal:  Front Cell Dev Biol       Date:  2022-03-01

9.  Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux.

Authors:  Sandhya Sankaranarayanan; John F Oram; Bela F Asztalos; Ashley M Vaughan; Sissel Lund-Katz; Maria Pia Adorni; Michael C Phillips; George H Rothblat
Journal:  J Lipid Res       Date:  2008-09-30       Impact factor: 5.922

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.